graphic
News
Pfizer earnings rise
April 18, 2001: 6:49 a.m. ET

No. 1 U.S. drugmaker earns 33 cents a share, two cents above forecasts
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Pfizer Inc. Wednesday said first-quarter earnings excluding one-time items jumped 35 percent, topping Wall Street forecasts, boosted by strong sales of its Lipitor anti-cholesterol drug and Celebrex for arthritis.

The biggest U.S. drugmaker, which also makes the anti-impotence drug Viagra, said it earned $2.13 billion, or 33 cents a share, in the quarter excluding one-time items and merger-related costs, up from $1.58 billion, or 25 cents a share, a year earlier.

Wall Street analysts had forecast profits of 31 cents a share for the latest quarter.

Sales rose 7 percent to about $7.6 billion from $7.2 billion, Pfizer said in a statement.

The New York-based company also said it sees earnings growth of at least 10 percent this year and projected earnings of $1.56 a share or better for 2002. Analysts are forecasting profits of $1.59 on average for 2002, according to First Call, which tracks earnings forecasts on Wall Street.

Pfizer (PFE: Research, Estimates) stock rose $1.51 to $42.41 Tuesday.

-- from staff and wire reports  graphic





graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.